Efficacy and tolerance of insulin degludec administered once/day in a pattern unique flexible compared to insulin glargine once daily at a fixed time in patients with type 2 diabetes (T2D)

被引：0
|
作者：
Huet, D. [1 ]
Atkin, S. [2 ]
Bain, S. [3 ]
Gough, S. [4 ]
Shestakova, M. [5 ]
Raz, I. [6 ,7 ]
Blonde, L. [8 ]
Meneghini, L. [9 ]
Begtrup, K. [10 ]
Johansen, T. [10 ]
Birkeland, K. [11 ,12 ]
机构：
[1] Grp Hosp Paris St Joseph, Paris, France
[2] Hull York Med Sch, Kingston Upon Hull, N Humberside, England
[3] Singleton Hosp, Swansea SA2 8QA, W Glam, Wales
[4] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
[5] Endocrinol Res Ctr, Moscow, Russia
[6] Hebrew Univ Jerusalem, Jerusalem, Israel
[7] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel
[8] Ochsner Med Ctr, New Orleans, LA USA
[9] Univ Miami, Miami, FL USA
[10] Novo Nordisk AS, Soborg, Denmark
[11] Univ Oslo, Oslo, Norway
[12] Oslo Univ Hosp, Oslo, Norway
来源：
DIABETES & METABOLISM | 2012年 / 38卷
关键词：
D O I：
10.1016/S1262-3636(12)71405-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：A102 / A102
页数：1
相关论文
共 50 条
  • [1] Insulin degludec does not compromise efficacy or safety when given in a flexible once-daily dosing regimen compared to insulin glargine once daily at the same time each day in type 2 diabetes
    Atkin, S. L.
    Bain, S. C.
    Gough, S.
    Shestakova, M. V.
    Raz, I.
    Blonde, L.
    Meneghini, L.
    Begtrup, K.
    Johansen, T.
    Birkeland, K. I.
    DIABETOLOGIA, 2011, 54 : S53 - S53
  • [2] Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study
    Kumar, S.
    Jang, H. C.
    Demirag, N. G.
    Skjoth, T. V.
    Endahl, L.
    Bode, B.
    DIABETIC MEDICINE, 2017, 34 (02) : 180 - 188
  • [3] ONCE-WEEKLY BASAL INSULIN FC (BIF) DEMONSTRATED SIMILAR GLYCEMIC CONTROL TO ONCE-DAILY INSULIN DEGLUDEC (DEG) IN INSULIN-NAIVE PATIENTS WITH TYPE 2 DIABETES (T2D)
    Bue-Valleskey, J.
    Kazda, C.
    Ma, C.
    Chien, J.
    Zhang, Q.
    Chigutsa, E.
    Landschulz, W.
    Swan, J.
    Haupt, A.
    Frias, J. P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A193 - A193
  • [4] Once Weekly (QW) Basal Insulin Fc (BIF) Demonstrated Similar Glycemic Control to Once Daily (QD) Insulin Degludec (DEG) in Insulin-Naive Patients with Type 2 Diabetes (T2D)
    Bue-Valleskey, Juliana M.
    Kazda, Christof M.
    Ma, Chenchen
    Chien, Jenny
    Zhang, Qianyi
    Chigutsa, Emmanuel
    Landschulz, William
    Swan, Jennifer
    Haupt, Axel
    Frias, Juan Pablo
    DIABETES, 2022, 71
  • [5] Efficacy and Safety of MK-1293 Insulin Glargine Compared with Originator Insulin Glargine (Lantus) in Type 2 Diabetes (T2D)
    Hollander, Priscilla
    Golm, Gregory
    Carofano, Wendy
    Eldor, Roy
    Crutchlow, Michael
    Marcos, Michael
    Rendell, Marc
    Home, Philip
    Gallwitz, Baptist
    Rosenstock, Julio
    DIABETES, 2016, 65 : A238 - A238
  • [6] Efficacy of Adding Once-Daily Insulin Glulisine in Japanese Type 2 Diabetes Patients Treated with Insulin Glargine and Sitagliptin
    Takahara, Mitsuyoshi
    Shiraiwa, Toshihiko
    Katakami, Naoto
    Matsuoka, Taka-aki
    Shimomura, Iichiro
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (10) : 633 - 639
  • [7] Once weekly basal insulin Fc demonstrated similar glycaemic control to once daily insulin degludec in insulin-naive patients with type 2 diabetes
    Bue-Valleskey, J. M.
    Kazda, C.
    Ma, C.
    Chien, J.
    Zhang, Q.
    Chigutsa, E.
    Landschulz, W.
    Swan, J.
    Haupt, A.
    Frias, J.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S334 - S334
  • [8] Efficacy and Safety of Insulin Degludec (IDeg) vs. Insulin Glargine U100 (IGlar) in Hispanic Patients with Type 2 Diabetes (T2D)
    Chaykin, Louis B.
    Bhargava, Anuj
    Wysham, Carol H.
    Abrahamsen, Trine
    Van Leeuwen, Michiel
    De la Rosa, Raymond
    DIABETES, 2017, 66 : A617 - A617
  • [9] Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus
    Yoshihara, T
    Kumashiro, N
    Kanazawa, Y
    Mita, T
    Sakurai, Y
    Kawai, J
    Abe, M
    Motojima, K
    Hara, K
    Yamazaki, Y
    Kanazawa, A
    Miwa, S
    Sato, F
    Kanno, R
    Shimizu, T
    Sakai, K
    Uchino, H
    Watada, H
    Tanaka, Y
    Kawamori, R
    Hirose, T
    ENDOCRINE JOURNAL, 2006, 53 (01) : 67 - 72
  • [10] CGM-Derived Parameters for Once-Weekly Insulin Icodec vs. Once Daily Insulin Glargine U100 in Insulin Na ve Patients with T2D
    Lingvay, Ildiko
    Bang, Rikke Beck
    Koefoed, Mette M.
    Mader, Julia K.
    Pettus, Jeremy
    Wagner, Lily
    Mathieu, Chantal
    DIABETES, 2021, 70
12345